District court

SHAREHOLDER ALERT: Pomerantz Law Reminds Shareholders with Losses on their Investment in Alico, Inc. of Class Action Lawsuit and Upcoming Deadline – ALCO

Retrieved on: 
Monday, February 20, 2023

NEW YORK, Feb. 20, 2023 (GLOBE NEWSWIRE) -- Pomerantz LLP announces that a class action lawsuit has been filed against Alico, Inc. (“Alico” or the “Company”) (NASDAQ: ALCO) and certain officers.

Key Points: 
  • NEW YORK, Feb. 20, 2023 (GLOBE NEWSWIRE) -- Pomerantz LLP announces that a class action lawsuit has been filed against Alico, Inc. (“Alico” or the “Company”) (NASDAQ: ALCO) and certain officers.
  • To discuss this action, contact Robert S. Willoughby at [email protected] or 888.476.6529 (or 888.4-POMLAW), toll-free, Ext.
  • Those who inquire by e-mail are encouraged to include their mailing address, telephone number, and the number of shares purchased.
  • Founded by the late Abraham L. Pomerantz, known as the dean of the class action bar, Pomerantz pioneered the field of securities class actions.

Gainey McKenna & Egleston Announces A Class Action Lawsuit Has Been Filed Against Inspirato Incorporated (ISPO)

Retrieved on: 
Monday, February 20, 2023

Investors who purchased or otherwise acquired shares of Inspirato should contact the Firm prior to the April 17, 2023 lead plaintiff motion deadline.

Key Points: 
  • Investors who purchased or otherwise acquired shares of Inspirato should contact the Firm prior to the April 17, 2023 lead plaintiff motion deadline.
  • A lead plaintiff is a representative party acting on behalf of other class members in directing the litigation.
  • If you wish to discuss your rights or interests regarding this class action, please contact Thomas J. McKenna, Esq.
  • of Gainey McKenna & Egleston at (212) 983-1300, or via e-mail at [email protected] or [email protected] .

Securities Class Action Lawsuit Reminder: Kessler Topaz Meltzer & Check, LLP Reminds Investors of Enovix Corporation That a Securities Fraud Class Action Lawsuit Has Been Filed on Their Behalf

Retrieved on: 
Monday, February 20, 2023

The action charges Enovix with violations of the federal securities laws, including omissions and fraudulent misrepresentations relating to the company’s business, operations, and prospects.

Key Points: 
  • The action charges Enovix with violations of the federal securities laws, including omissions and fraudulent misrepresentations relating to the company’s business, operations, and prospects.
  • As a result of Enovix’s materially misleading statements and omissions to the public, Enovix’s investors have suffered significant losses.
  • On July 14, 2021, Enovix was officially acquired by Rodgers Silicon Valley Acquisition Corp., a special purpose acquisition company.
  • Kessler Topaz Meltzer & Check, LLP encourages Enovix investors who have suffered significant losses to contact the firm directly to acquire more information.

KORNIT DIGITAL LTD. (NASDAQ: KRNT) SHAREHOLDER CLASS ACTION ALERT: Bernstein Liebhard LLP Announces that a Securities Class Action Lawsuit Has Been Filed Against Kornit Digital Ltd. (NASDAQ: KRNT)

Retrieved on: 
Thursday, February 16, 2023

NEW YORK, Feb. 16, 2023 (GLOBE NEWSWIRE) -- Bernstein Liebhard LLP announces that a securities class action lawsuit has been filed on behalf of investors who purchased or acquired the ordinary shares of Kornit Digital Ltd. (“Kornit” or the “Company”) (NASDAQ: KRNT) between February 17, 2021 and July 5, 2022, inclusive (the “Class Period”). The lawsuit was filed in the United States District Court for the District of New Jersey and alleges violations of the Securities Exchange Act of 1934.

Key Points: 
  • Shareholder Class Action Lawsuit or contact Peter Allocco at (212) 951-2030 or [email protected] to discuss your rights.
  • The lawsuit was filed in the United States District Court for the District of New Jersey and alleges violations of the Securities Exchange Act of 1934.
  • Kornit designs and manufactures industrial digital printing technologies for the garment, apparel, and textile industries.
  • The law firm responsible for this advertisement is Bernstein Liebhard LLP, 10 East 40th Street, New York, New York 10016, (212) 779-1414.

Pomerantz Law Firm Announces Consolidation of Class Actions Against Anker Innovations Limited and Fantasia Trading LLC

Retrieved on: 
Wednesday, February 15, 2023

NEW YORK, Feb. 15, 2023 (GLOBE NEWSWIRE) -- Pomerantz LLP announces that two class action lawsuits against Anker Innovations Limited (“Anker” or the “Company”) and Fantasia Trading LLC (“Fantasia”) captioned Sloan v. Anker Tech.

Key Points: 
  • NEW YORK, Feb. 15, 2023 (GLOBE NEWSWIRE) -- Pomerantz LLP announces that two class action lawsuits against Anker Innovations Limited (“Anker” or the “Company”) and Fantasia Trading LLC (“Fantasia”) captioned Sloan v. Anker Tech.
  • 1:22-cv-07174 (N.D. Ill.), and Bleiberg v. Anker Innovations Limited, et al.
  • Founded by the late Abraham L. Pomerantz, known as the dean of the class action bar, Pomerantz pioneered the field of securities class actions.
  • The Firm has recovered numerous multimillion-dollar damages awards on behalf of class members.

CLASS ACTION NOTICE: Kessler Topaz Meltzer & Check, LLP Reminds Investors that a Securities Fraud Class Action Lawsuit Filed against Enovix Corporation

Retrieved on: 
Wednesday, February 15, 2023

The action charges Enovix with violations of the federal securities laws, including omissions and fraudulent misrepresentations relating to the company’s business, operations, and prospects.

Key Points: 
  • The action charges Enovix with violations of the federal securities laws, including omissions and fraudulent misrepresentations relating to the company’s business, operations, and prospects.
  • As a result of Enovix’s materially misleading statements and omissions to the public, Enovix’s investors have suffered significant losses.
  • On July 14, 2021, Enovix was officially acquired by Rodgers Silicon Valley Acquisition Corp., a special purpose acquisition company.
  • Kessler Topaz Meltzer & Check, LLP encourages Enovix investors who have suffered significant losses to contact the firm directly to acquire more information.

SOTERA HEALTH SHAREHOLDER ALERT: CLAIMSFILER REMINDS INVESTORS WITH LOSSES IN EXCESS OF $100,000 of Lead Plaintiff Deadline in Class Action Lawsuit Against Sotera Health Company - SHC

Retrieved on: 
Wednesday, February 15, 2023

NEW ORLEANS, Feb. 14, 2023 (GLOBE NEWSWIRE) -- ClaimsFiler, a FREE shareholder information service, reminds investors that they have until March 27, 2023 to file lead plaintiff applications in a securities class action lawsuit against Sotera Health Company (NasdaqGS: SHC), if they purchased or otherwise acquired the Company’s shares (i) pursuant and/or traceable to the Company’s November 2020 initial public offering (the “IPO”); (ii) pursuant and/or traceable to the Company’s March 2021 secondary public offering (the “SPO,” and together with the IPO, the “Offerings”); and/or (iii) between November 20, 2020 and September 19, 2022, inclusive (the “Class Period”).

Key Points: 
  • NEW ORLEANS, Feb. 14, 2023 (GLOBE NEWSWIRE) -- ClaimsFiler, a FREE shareholder information service, reminds investors that they have until March 27, 2023 to file lead plaintiff applications in a securities class action lawsuit against Sotera Health Company (NasdaqGS: SHC), if they purchased or otherwise acquired the Company’s shares (i) pursuant and/or traceable to the Company’s November 2020 initial public offering (the “IPO”); (ii) pursuant and/or traceable to the Company’s March 2021 secondary public offering (the “SPO,” and together with the IPO, the “Offerings”); and/or (iii) between November 20, 2020 and September 19, 2022, inclusive (the “Class Period”).
  • This action is pending in the United States District Court for the Northern District of Ohio.
  • Sotera investors should visit us at https://claimsfiler.com/cases/nasdaq-shc/ or call toll-free (844) 367-9658.
  • Lawyers at Kahn Swick & Foti, LLC are available to discuss your legal options.

INVIVYD SHAREHOLDER ALERT: CLAIMSFILER REMINDS INVESTORS WITH LOSSES IN EXCESS OF $100,000 of Lead Plaintiff Deadline in Class Action Lawsuit Against Invivyd, Inc. – IVVD, ADGI

Retrieved on: 
Wednesday, February 15, 2023

NEW ORLEANS, Feb. 14, 2023 (GLOBE NEWSWIRE) -- ClaimsFiler, a FREE shareholder information service, reminds investors that they have until April 3, 2023 to file lead plaintiff applications in a securities class action lawsuit against Invivyd, Inc. (the “Company”) (NasdaqGM: IVVD) f/k/a Adagio Therapeutics, Inc. (“Adagio”) (NasdaqGM: ADGI), if they purchased the Company’s shares between November 29, 2021 and December 14, 2021, inclusive (the “Class Period”).

Key Points: 
  • NEW ORLEANS, Feb. 14, 2023 (GLOBE NEWSWIRE) -- ClaimsFiler, a FREE shareholder information service, reminds investors that they have until April 3, 2023 to file lead plaintiff applications in a securities class action lawsuit against Invivyd, Inc. (the “Company”) (NasdaqGM: IVVD) f/k/a Adagio Therapeutics, Inc. (“Adagio”) (NasdaqGM: ADGI), if they purchased the Company’s shares between November 29, 2021 and December 14, 2021, inclusive (the “Class Period”).
  • This action is pending in the United States District Court for the District of Massachusetts.
  • Invivyd investors should visit us at https://claimsfiler.com/cases/nasdaq-ivvd/ or call toll-free (844) 367-9658.
  • Lawyers at Kahn Swick & Foti, LLC are available to discuss your legal options.

Y-MABS THERAPEUTICS SHAREHOLDER ALERT: CLAIMSFILER REMINDS INVESTORS WITH LOSSES IN EXCESS OF $100,000 of Lead Plaintiff Deadline in Class Action Lawsuit Against Y-mAbs Therapeutics, Inc. - YMAB

Retrieved on: 
Wednesday, February 15, 2023

NEW ORLEANS, Feb. 14, 2023 (GLOBE NEWSWIRE) -- ClaimsFiler, a FREE shareholder information service, reminds investors that they have until March 20, 2023 to file lead plaintiff applications in a securities class action lawsuit against Y-mAbs Therapeutics, Inc. (NasdaqGS: YMAB), if they purchased the Company’s securities between October 6, 2020 and October 28, 2022, inclusive (the “Class Period”).

Key Points: 
  • NEW ORLEANS, Feb. 14, 2023 (GLOBE NEWSWIRE) -- ClaimsFiler, a FREE shareholder information service, reminds investors that they have until March 20, 2023 to file lead plaintiff applications in a securities class action lawsuit against Y-mAbs Therapeutics, Inc. (NasdaqGS: YMAB), if they purchased the Company’s securities between October 6, 2020 and October 28, 2022, inclusive (the “Class Period”).
  • This action is pending in the United States District Court for the Southern District of New York.
  • Y-mAbs investors should visit us at https://claimsfiler.com/cases/nasdaq-ymab/ or call toll-free (844) 367-9658.
  • Lawyers at Kahn Swick & Foti, LLC are available to discuss your legal options.

ENOVIX CORPORATION SHAREHOLDER ALERT: CLAIMSFILER REMINDS INVESTORS WITH LOSSES IN EXCESS OF $100,000 of Lead Plaintiff Deadline in Class Action Lawsuit Against Enovix Corporation - ENVX

Retrieved on: 
Wednesday, February 15, 2023

NEW ORLEANS, Feb. 14, 2023 (GLOBE NEWSWIRE) -- ClaimsFiler, a FREE shareholder information service, reminds investors that they have until March 7, 2023 to file lead plaintiff applications in a securities class action lawsuit against Enovix Corporation (“the Company”) f/k/a Rodgers Silicon Valley Acquisition Corp. (NasdaqGS: ENVX), if they purchased or otherwise acquired the Company’s shares between February 22, 2021 and January 3, 2023, inclusive (the “Class Period”), including shares of Rodgers Silicon prior to July 15, 2021.

Key Points: 
  • NEW ORLEANS, Feb. 14, 2023 (GLOBE NEWSWIRE) -- ClaimsFiler, a FREE shareholder information service, reminds investors that they have until March 7, 2023 to file lead plaintiff applications in a securities class action lawsuit against Enovix Corporation (“the Company”) f/k/a Rodgers Silicon Valley Acquisition Corp. (NasdaqGS: ENVX), if they purchased or otherwise acquired the Company’s shares between February 22, 2021 and January 3, 2023, inclusive (the “Class Period”), including shares of Rodgers Silicon prior to July 15, 2021.
  • This action is pending in the United States District Court for the Northern District of California.
  • Enovix investors should visit us at https://claimsfiler.com/cases/nasdaq-envx/ or call toll-free (844) 367-9658.
  • Lawyers at Kahn Swick & Foti, LLC are available to discuss your legal options.